Literature DB >> 31305216

Advances in Raman imaging combined with AFM and fluorescence microscopy are beneficial for oncology and cancer research.

Halina Abramczyk1, Anna Imiela1, Beata Brozek-Pluska1, Monika Kopec1.   

Abstract

Aim: The aim of this paper is to provide images of the universal cancer Raman biomarkers based on lipidomic, proteomic, glycomic profiles and nanomechanical properties. Materials & methods: Biochemical mapping and nanomechanical properties (topography, stiffness and adhesion) of human breast and brain for normal and cancer tissues and cell culture line U87 MG of glioblastoma were obtained using Raman imaging combined with atomic force microscopy (AFM) and fluorescence microscopy. Results & conclusion: Detailed analysis of breast ductal carcinoma in situ, and astrocytoma brain tissues as well as cells of glioblastoma U87 MG showed that Raman scattering generates images as accurately as histology hematoxylin and eosin stain used in clinical practice with additional advantage of biochemical information. Combination of AFM maps and Raman images allows to correlate mechanical properties with biochemical composition of cells.

Entities:  

Keywords:  AFM; Raman imaging; adhesion; brain tumor; breast cancer; stiffness

Mesh:

Substances:

Year:  2019        PMID: 31305216     DOI: 10.2217/nnm-2018-0335

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  2 in total

1.  Oxidative stress induced by tBHP in human normal colon cells by label free Raman spectroscopy and imaging. The protective role of natural antioxidants in the form of β-carotene.

Authors:  B Brozek-Pluska; K Beton
Journal:  RSC Adv       Date:  2021-05-04       Impact factor: 4.036

2.  Revision of Commonly Accepted Warburg Mechanism of Cancer Development: Redox-Sensitive Mitochondrial Cytochromes in Breast and Brain Cancers by Raman Imaging.

Authors:  Halina Abramczyk; Jakub Maciej Surmacki; Beata Brozek-Pluska; Monika Kopec
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.